Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

27 févr. 2026 20h57 HE | Source: Breezemeds

BreezeMeds GLP-1 Weight Loss 2026: Compounded Semaglutide and Tirzepatide Pricing (From $199), FDA Regulatory Status Examined

Independent 2026 overview examines BreezeMeds compounded GLP-1 semaglutide telehealth pricing, FDA regulatory status, and what to verify first.
05 févr. 2026 19h53 HE | Source: PharmaZee

PharmaZee GLP-1 Prescription Information Updated as Novo Nordisk Raises Compounding Concerns and Consumer Interest in Telehealth Semaglutide Access Grows in 2026

PharmaZee telehealth platform information updated. Examining compounded vs FDA-approved GLP-1s amid Novo Nordisk compounding statement Feb 2026.
30 déc. 2025 20h57 HE | Source: Direct Meds

Best Wegovy Alternative for 2026? FDA Approves Oral Semaglutide as Patients Evaluate Compounded Telehealth Access — Direct Meds Examined as Verification Case Study

Industry analysis examines how patients verify telehealth GLP-1 platforms after FDA oral semaglutide approval. Direct Meds included as case study.